Immediate Impact
2 by Nobel laureates 3 from Science/Nature 50 standout
Citing Papers
Small and long non-coding RNAs: Past, present, and future
2024 Standout
Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Works of Wendell Davis being referenced
Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Wendell Davis | 52 | 57 | 70 | 21 | 315 | |
| Akhalesh Kumar Shakya | 11 | 59 | 61 | 22 | 350 | |
| Kenshi Kumamoto | 35 | 62 | 33 | 28 | 343 | |
| F. Joy Archer | 22 | 52 | 139 | 15 | 360 | |
| Xue Yang | 21 | 32 | 60 | 14 | 271 | |
| Erik Ulfhammer | 25 | 152 | 54 | 18 | 353 | |
| Xu Liu | 35 | 102 | 15 | 28 | 296 | |
| Zhentao Guo | 16 | 87 | 17 | 25 | 269 | |
| Timothy P. Welch | 21 | 64 | 30 | 13 | 366 | |
| Biruk Kassa | 174 | 71 | 72 | 19 | 299 | |
| Xinglu Chen | 36 | 165 | 69 | 20 | 343 |
All Works
Loading papers...